Overview
- A single-site, five-year study from Monash University published in Nature on Wednesday used fMRI, EEG and machine learning in 62 healthy volunteers to map brain activity before and after psilocybin.
- Researchers found a pattern they call “context alignment,” where psilocybin reshapes neural dynamics so moment-by-moment brain activity more closely tracks what a person is doing or experiencing rather than becoming simple neural noise.
- Objective changes included an 85 percent narrowing of the normal eyes-open versus eyes-closed connectivity gap in the visual network, reduced alpha-band EEG power, and increased overall signal complexity across the brain.
- Stronger context alignment correlated with positive, boundary-dissolving experiences and short-term gains in measures like personal meaning and nature relatedness, but the study used psychedelic‑naïve healthy volunteers who knew they received psilocybin, limiting claims about therapeutic benefit.
- The finding restores a central role for set and setting in psychedelic work, points to machine-learning signatures that could become individual biomarkers, and the authors call for replication, tests in patient groups, and efforts to predict who may benefit from treatment.